.
MergerLinks Header Logo

New Deal


Announced

Everlife-backed CPC Diagnostics completed the acquisition of the POCT division of Weldon Biotech and SM Biotech.

Synopsis

Everlife-backed CPC Diagnostics, a provider of clinical diagnostic products and services, completed the acquisition of the POCT division of Weldon Biotech, a manufacturer and distributor of in vitro diagnostic products, and SM Biotech, a unit of mushroom machinery manufacturing. Financial terms were not disclosed.

Show Details & Financials

Market Context

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US